Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01000441
What this trial is testing

Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
University Hospital, Strasbourg, France 300
Testing effectiveness (Phase 2)Study completedNCT01668641
What this trial is testing

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748728
What this trial is testing

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd 90
Testing effectiveness (Phase 2)Study completedNCT01389973
What this trial is testing

Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid

Who this might be right for
Primary Biliary Cirrhosis
Janssen Research & Development, LLC 20
Not applicableStudy completedNCT05206422
What this trial is testing

DORAYA-HF Early Feasibility Study

Who this might be right for
Acute Decompensated Heart Failure
Revamp Medical Inc. 21
Testing effectiveness (Phase 2)Study completedNCT05374785
What this trial is testing

Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celon Pharma SA 106
Large-scale testing (Phase 3)Looking for participantsNCT04871191
What this trial is testing

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

Who this might be right for
Granulomatosis With PolyangiitisAnti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Assistance Publique - Hôpitaux de Paris 42
Large-scale testing (Phase 3)Study completedNCT02012218
What this trial is testing

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 61
Large-scale testing (Phase 3)Study completedNCT00574249
What this trial is testing

Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

Who this might be right for
Chronic Plaque Psoriasis
Abbott 730
Large-scale testing (Phase 3)Study completedNCT02675426
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 661
Large-scale testing (Phase 3)Study completedNCT00503425
What this trial is testing

MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Testing effectiveness (Phase 2)Study completedNCT01851707
What this trial is testing

Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Who this might be right for
Rheumatoid Arthritis
SecuraBio 322
Post-approval studies (Phase 4)Looking for participantsNCT07634484
What this trial is testing

A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins

Who this might be right for
Hypercholesterolemia
Kowa Company, Ltd. 120
Large-scale testing (Phase 3)Study completedNCT02272517
What this trial is testing

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 101
Testing effectiveness (Phase 2)Study completedNCT03394924
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Enanta Pharmaceuticals, Inc 68
Large-scale testing (Phase 3)Active Not RecruitingNCT06079879
What this trial is testing

Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Who this might be right for
Essential Thrombocythemia
Merck Sharp & Dohme LLC 340
Large-scale testing (Phase 3)Study completedNCT03016013
What this trial is testing

The Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.

Who this might be right for
Moderate and Severe RheumatoId Arthritis
RemeGen Co., Ltd. 479
Not applicableStudy completedNCT01617005
What this trial is testing

Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT03881488
What this trial is testing

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerNon-small Cell Lung Cancer+4 more
Compass Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT03760003
What this trial is testing

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 355
Next Page